Oncology Drug Approval - Accelerated

Bridging the gap between biomarkers and In Vitro Companion Diagnostics

Board of Directors

Sheridan Snyder, LLB (Hon) - Chairman

Chad Galderisi, D.O. - Vice President of Medical Affairs, MolecularMD

Frederick “Fritz” Eibel, Senior Vice President of Strategic Marketing, RainDance Technologies, Inc.

Matt Rice, MBA - Principal, Ballast Point Ventures

Peter Maag, Ph.D. - President and Chief Executive Officer, XDx, Inc.

Dan Snyder, MBA - President and Chief Executive Officer, MolecularMD

MolecularMD discusses the clinical application of liquid biopsy or circulating tumor DNA (ctDNA) and its benefits within the field of oncology and companion diagnostics.